Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 29 Oct 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Influenza virus vaccine (Primary) ; Influenza vaccine quadrivalent Seqirus
Indications Influenza virus infections
Focus Therapeutic Use
Acronyms DANFLU-1; QHD00027

02 Sep 2024 Results of post hoc analysis of this trial explaining QIV-HD association with lower incidence of hospitalisation for pneumonia or influenza with respect to time of day for vaccination, presented at the ESC Congress 2024 - Annual Congress of the European Society of Cardiology
20 Aug 2022 Status changed from active, no longer recruiting to completed.
25 Apr 2022 Status changed from recruiting to active, no longer recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com